Bedal International to Boost its Growth With New Funding

Bedal International has gained $11 million (€10.2 million) in funding to support its ongoing global growth. 
 
The financing was led by White Fund, a Belgian medtech venture capital fund, and SFPIM, Belgium’s sovereign wealth fund. Other participants included U.S.-based medtech investors, as well as Bedal’s leading existing investors, F3Finance and LRM. Bedal management also lended its financial support.
 
“Since we founded Bedal, it has already been an incredible journey from launching the devices to growing into a global footprint.” Bedal International CEO Alexander Van Damme said. “This new funding marks the beginning of a next chapter for us, focused on setting a new standard in the market.”
 
Bedal markets the FlexGRIP catheter securement devices, which help patients safely secure their catheters, reduce possible complications, and improve overall patient outcomes. The FlexGRIP devices are in use in more then 34 countries globally, and Bedal claims it has succesfully closed global deals with leading catheter companies. The additional funding will allow Bedal to expand its operations and commercial efforts, with a strong focus on growing its U.S. market presence.
 
“White Fund and SFPIM are excited to support Bedal’s mission to improve patient care through its innovative devices,” said Eric Brandt of White Fund.

“We believe in Bedal’s potential to become the golden standard for catheter care. We are proud to be part of their promising growth journey and are committed to supporting their product development engine with the ambition of making a profound impact on the lives of patients and caregivers,” added Céline Vaessen, CIO at SFPIM.
 
Previously, Bedal attracted industry veteran Steve Bierman, M.D., who helped develop the catheter securement market. Bierman is Bedal’s co-CEO. The company was founded based on the experiences of one of the founders, who discovered the challenges of catheter care during his cancer treatment. The FlexGRIP devices are used hospital wide in applications such as cancer treatment, post-operative care and the ICU. Recently, Bedal also launched a pediatric range of products, tailored to the needs of young patients.
 
White Fund is a Belgian venture capitalist fund specifically dedicated to the medtech sector and positions itself as a high value-added investment fund. In addition to its finance mission, White Fund aims to support companies in the key stages of their development. Its multi-disciplinary team and extensive network, with experience of both medtech expertise and the world of investment, are key assets for portfolio companies.
 
The Federal Participation and Investment Company (SFPIM) is Belgium’s Sovereign Wealth Fund. SFPIM aims to be a reliable partner for Belgian companies, both SMEs and scale-ups, helping them become leaders in their sectors by offering “smart capital solutions.” SFPIM also plays a significant role in ensuring the long-term stability of the Belgian economy by contributing to the anchoring of strategic assets through “smart capital solutions” in both promising and established companies or ecosystems.
SFPIM invests in a wide range of companies and sectors, including life sciences, finance, aerospace, energy, transport and mobility, and impact investing. 
 
F3 Finance is a niche investment boutique for family investors and entrepreneurs. 
 
LRM is a return-driven investment company that fosters and stimulates sustainable economic growth in and from Limburg. 
 
Bedal International focuses on specialized catheter securement solutions. The FlexGRIP products prioritize patient well-being and healthcare provider convenience.The company maintains offices in Belgium and Anaheim, Calif.